Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsFRA:UTM -2.50%73 Gross Margin % is 55.79% as of Jun. 2026, which is 9% below its 10-year median of 61.08. GuruFocus rates FRA:UTM with a GF Score™ of 73/100 and a GF Value™ of €49.20. The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Utah Medical Products ranks better than 59.58% on this metric.
FRA:UTM's Gross Margin % is ranked better than 59.58% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.34
vs FRA:UTM: 57.90
Utah Medical Products had a gross margin of 55.79% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Utah Medical Products was -1.50% per year.
Utah Medical Products (FRA:UTM) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Utah Medical Products had a gross margin of 55.79% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Utah Medical Products Gross Margin % Related Terms
Utah Medical Products Gross Margin % Historical Data
* Premium members only.
The historical data trend for Utah Medical Products's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:UTM vs EMBC, SMTI, PDEX: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Utah Medical Products's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Utah Medical Products (FRA:UTM) has a Gross Margin % of 55.79% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Utah Medical Products and its competitors. This is near median its historical median of 61.08. Over the past decade, Utah Medical Products' Gross Margin % has ranged from 57.12 to 63.73. According to the industry distribution chart, Utah Medical Products ranks #325 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 40.4%.
Is Utah Medical Products' Gross Margin % too high?
Utah Medical Products' current Gross Margin % of 55.79% is near median its 10-year median of 61.08. Over the past 10 years, this metric has ranged from a low of 57.12 to a high of 63.73. The Medical Devices & Instruments industry median Gross Margin % is 52.34. Utah Medical Products' value of 55.79% is 6.6% above this industry median. Based on the distribution chart, Utah Medical Products ranks #325 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Utah Medical Products has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' Gross Margin % compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #325 out of 804 companies for Gross Margin %. This puts Utah Medical Products in the upper half of its industry. The industry median Gross Margin % is 52.34. Utah Medical Products' value of 55.79% is 6.6% above this benchmark. Historically, Utah Medical Products' own Gross Margin % has ranged from 57.12 to 63.73 over the past decade. While the company's 10-year median is 61.08 vs. the industry median of 52.34, Utah Medical Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.34, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current Gross Margin % of 55.79% is 6.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current Gross Margin % is 55.79%, which is near median its own 10-year median of 61.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Utah Medical Products (FRA:UTM) has a current Gross Margin % of 55.79%. The stock's GF Value™ is €49.20, compared to a current price of €58.50 — trading 18.9% above its estimated fair value. The current Gross Margin % is 55.79%, which is near median its 10-year median of 61.08 and 6.6% above the Medical Devices & Instruments industry median of 52.34. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Utah Medical Products (FRA:UTM), the current Gross Margin % is 55.79% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (FRA:UTM) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of €58.50 is trading 18.9% above its estimated GF Value™ of €49.20.
Key valuation signals for FRA:UTM:
Gross Margin %: 55.79% (near median its 10-year median of 61.08)
GF Value™: €49.20 vs. price of €58.50 (18.9% above fair value)
Industry Position: 6.6% above the Medical Devices & Instruments median (#325 of 804)
No single metric tells the full story. See the FRA:UTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for FRA:UTM
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UTM has been successfully added to your 
